Recent progress in research on myeloid CLRs has revealed that in addition to the host defense against pathogens, these molecules play important roles in the homeostasis of muco‐epithelial immunity and development of diseases, including colitis, asthma, psoriasis, atopic dermatitis, and cancers. This evidence concerns the gene LARS1 and cancer.